Lantheus Holdings, Inc. (LNTH)

NASDAQ: LNTH · Real-Time Price · USD

56.82

-0.51 (-0.89%)

Oct 29, 2025, 1:18 PM EDT - Market open

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
PYLARIFY Revenue	1.03B	1.06B	Log In	Log In	Log In	Upgrade
Other Radiopharmaceutical Oncology Revenue	-	384.00K	Log In	Log In	Log In	Upgrade
Total Radiopharmaceutical Oncology Revenue	1.03B	1.06B	Log In	Log In	Log In	Upgrade
DEFINITY Revenue	326.28M	317.79M	Log In	Log In	Log In	Upgrade
TechneLite Revenue	90.28M	95.49M	Log In	Log In	Log In	Upgrade
Other Precision Diagnostics Revenue	24.81M	24.23M	Log In	Log In	Log In	Upgrade
Total Precision Diagnostics Revenue	441.37M	437.51M	Log In	Log In	Log In	Upgrade
Strategic Partnerships and Other Revenue	45.28M	38.18M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-1.48B	-1.50B	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.52B	1.53B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Product Revenue	1.50B	1.52B	Log In	Log In	Log In	Upgrade
License and Royalty Revenue	16.48M	9.13M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.52B	1.53B	Log In	Log In	Log In	Upgrade

Updated Aug 6, 2025. Data Source: Fiscal.ai.